First episode of major depressive disorder and vascular factors in coronary artery disease patients: Baseline characteristics and response to antidepressant treatment in the CREATE trial

Journal of Psychosomatic Research
Martine E HabraFrançois Lespérance

Abstract

The CREATE trial reported that coronary artery disease (CAD) patients suffering from a first depression derived less benefit from citalopram relative to placebo than those with a recurrent depression. The present investigation sought to determine whether the differential benefit of citalopram between those with a first depression and those with recurrent depression could be explained by indicators of vascular depression and cardiac disease severity. Secondary analyses of data from CREATE, a 12-week, randomized placebo-controlled trial of 284 patients with major depressive disorder and CAD were used. Recurrence subgroups were compared on baseline characteristics reflecting vascular depression and cardiac disease severity. Outcome measures were the mean change from baseline to 12 weeks on the 24-item Hamilton Depression Rating Scale administered centrally by telephone. ANCOVA was used to assess the potential interaction of each baseline variable with citalopram/placebo treatment in predicting outcomes. Few baseline differences differentiated patients with a first versus recurrent depression, and none accounted for the differential treatment efficacy in these subgroups. Patients with a cardiac event in the past 6 months (P=.02) an...Continue Reading

References

Jun 1, 1990·Archives of General Psychiatry·J K SargeantM M Weissman
Feb 1, 1995·Medical Hypotheses·K R Krishnan, W M McDonald
Jan 1, 1994·Stroke; a Journal of Cerebral Circulation·R B D'AgostinoW B Kannel
Nov 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·H BrodatyK Eyers
Apr 1, 1996·Archives of General Psychiatry·G S AlexopoulosE Rosendahl
Mar 1, 1997·Stroke; a Journal of Cerebral Circulation·L Pantoni, J H Garcia
Oct 24, 1997·Archives of General Psychiatry·G S AlexopoulosM Charlson
Jan 16, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Stephen SallowayRaj Nakra
Feb 2, 2002·The American Journal of Psychiatry·Michael A PosternakIvan W Miller
Mar 13, 2002·Circulation·Johann W AuerBernd Eber
Mar 29, 2002·International Journal of Geriatric Psychiatry·Hayden B BosworthDavid C Steffens
Jul 16, 2002·JAMA : the Journal of the American Medical Association·Dennis T KoHarlan M Krumholz
Sep 6, 2002·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Mark D MillerCharles F Reynolds
Jan 23, 2003·Brain : a Journal of Neurology·Ahamad HassanHugh S Markus
Jul 2, 2003·The American Journal of Psychiatry·Lon S SchneiderUNKNOWN Sertraline Elderly Depression Study Group
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Jan 17, 2004·Stroke; a Journal of Cerebral Circulation·Merrill F EliasPhilip A Wolf
Feb 13, 2004·Biological Psychiatry·K Ranga Rama KrishnanDavid C Steffens
Sep 2, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George S AlexopoulosMoonseong Heo
Oct 30, 2004·The American Journal of Psychiatry·Steven P RooseUNKNOWN Old-Old Depression Study Group
Jul 16, 2005·International Journal of Geriatric Psychiatry·Henry C DriscollCharles F Reynolds
Aug 3, 2005·Circulation·E J van DijkM M B Breteler
Apr 4, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Alan Schatzberg, Steven Roose
Sep 26, 2006·Biological Psychiatry·Joel R SneedHarold A Sackeim
Dec 13, 2006·Journal of the American College of Cardiology·Peter de JongeJohan Ormel
Dec 22, 2006·Contemporary Clinical Trials·Irving Kirsch, Joanna Moncrieff
Apr 24, 2007·Journal of Affective Disorders·Fiona McDougall, Carol Brayne
Jun 26, 2007·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Joel R SneedHarold A Sackeim
Aug 10, 2007·The Journal of Clinical Psychiatry·Daniel SoueryUNKNOWN Group for the Study of Resistant Depression
Apr 25, 2008·Psychosomatic Medicine·Chris DickensFrancis Creed
Mar 3, 2009·Psychosomatic Medicine·Robert M CarneyAllan S Jaffe
Mar 18, 2009·The American Journal of Psychiatry·Robert M Carney, Kenneth E Freedland

❮ Previous
Next ❯

Citations

Jan 31, 2012·Neurologic Clinics·Nadejda AlekseevaAlireza Minagar
Jul 10, 2012·General Hospital Psychiatry·Bernhard T BauneKlaus Berger
Jul 20, 2011·Journal of Psychosomatic Research·Lydia PooleAndrew Steptoe
May 31, 2018·Scientific Reports·Pantelis CharisiadisJana V van Vliet-Ostaptchouk
Dec 5, 2019·Journal of Alzheimer's Disease : JAD·Juhan ReimandFemke Bouwman
Aug 2, 2017·BMC Medicine·João VianBrisa S Fernandes
Jan 8, 2013·Depression and Anxiety·Nicole Mavrides, Charles Nemeroff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.